scholarly journals Psychotropic medication use in treatment‐seeking youth with eating disorders

2020 ◽  
Vol 28 (6) ◽  
pp. 739-749 ◽  
Author(s):  
Sasha Gorrell ◽  
Jocelyn Lebow ◽  
Kathryn Kinasz ◽  
James E. Mitchell ◽  
Andrea B. Goldschmidt ◽  
...  
Keyword(s):  
Eating Disorders ◽  
Psychotropic Medication ◽  
Medication Use ◽  
Treatment Seeking

Fetal neurobehavioral sequelae of maternal psychotropic medication use during pregnancy

2014 ◽  
Author(s):  
Kate Touchton-Leonard ◽  
Malavika Dorai ◽  
Alison B. Corbin ◽  
Hanna C. Gustafsson ◽  
Zachary N. Stowe ◽  
...  
Keyword(s):  
Psychotropic Medication ◽  
Medication Use

Psychotropic Medication Use in Adolescents With Autism Spectrum Disorder

2012 ◽  
Author(s):  
Melissa P. Maye ◽  
Timothy W. Soto ◽  
Frances Martinez-Pedraza ◽  
Deborah K. Anderson ◽  
Catherine Lord ◽  
...  
Keyword(s):  
Autism Spectrum Disorder ◽  
Psychotropic Medication ◽  
Medication Use ◽  
Autism Spectrum ◽  
Spectrum Disorder ◽  
Adolescents With Autism

Psychotropic medication use among personality disordered young adults. A follow-up study among former adolescent psychiatric inpatients

2020 ◽  
Vol 293 ◽  
pp. 113449
Author(s):  
Liisa Kantojärvi ◽  
Helinä Hakko ◽  
Milla Mukka ◽  
Anniina Käyhkö ◽  
Pirkko Riipinen ◽  
...  
Keyword(s):  
Young Adults ◽  
Psychotropic Medication ◽  
Medication Use ◽  
Psychiatric Inpatients ◽  
Follow Up Study ◽  
Personality Disordered

Improving psychotropic medication use among persons with dementia

2016 ◽  
Vol 28 (10) ◽  
pp. 1587-1588 ◽  
Author(s):  
Donovan T. Maust
Keyword(s):  
United States ◽  
Older Adults ◽  
Nursing Home ◽  
Psychotropic Medication ◽  
Medication Use ◽  
The United States ◽  
Black Box ◽  
Community Settings ◽  
Limited Evidence

The use of psychotropic medication among persons with dementia (PWD) both in nursing home (Wetzels et al., 2011) and community settings (Maust et al., 2016) far exceeds what might be expected based on their limited evidence for benefit (Kales et al., 2015). This relatively high use persists despite years of evidence about the potential harms associated with their use in older adults generally and PWD in particular (e.g. Wang et al., 2001; Schneider et al., 2005). However, the solution to relatively high psychotropic use is not to end all psychotropic use, as there are individual patients for whom use of such medication is appropriate. For example, a policy that defines all antipsychotic use as inappropriate may simply lead to increased use of alternatives with even less evidence of benefit, as suggested by the response to antipsychotics’ black box warning in the United States (Kales et al., 2011).

Sign in / Sign up

Export Citation Format

Share Document